申请人:Smith Kline & French Laboratories Limited
公开号:US04093725A1
公开(公告)日:1978-06-06
The compounds are substituted hydrazinophthalazines which are active as .beta.-adrenergic blocking agents and as vasodilators. A specific compound of the invention is 5-(3-t-butylamino-2-hydroxypropoxy)-1-hydrazinophthalazine.
这些化合物是替代的肼基邻苯二酮,作为β-肾上腺素受体阻滞剂和血管扩张剂具有活性。该发明的特定化合物是5-(3-t-丁基氨基-2-羟基丙氧基)-1-肼基邻苯二酮。